Due to her wealth of experience, Colette McIntyre, HeartSine’s Good Laboratory Practice/Good Clinical Practice Specialist, has been appointed to the medical devices committee of the Research Quality Association (RQA).
The RQA, an association for professionals working in research in pharmaceuticals, agrochemicals, chemicals and medical devices, drives quality and integrity in scientific research and development by developing and promoting quality standards in scientific research and development, facilitating knowledge sharing and transfer, and liaising with regulatory agencies in the development and interpretation of regulations and guidance.
The Medical Devices Committee of the RQA seeks to support the association’s strategy, to provide a forum for discussion and clarification of medical device issues, to assist the association to play an active role in any consultative process related to medical device matters, and to promote effective liaison and provide informed opinion to regulatory bodies on medical device matters.
In her role within HeartSine’s Clinical department, McIntyre ensures when conducting pre-clinical or clinical studies, the company complies with the requirements of the Good Laboratory Practice and Good Clinical Practice regulations.
“Colette brings to the committee her more than 25 years of experience in quality system development and quality management in the medical devices, telecommunications and automotive sectors,” says Rebecca DiMaio, Ph.D., HeartSine’s Clinical Research Manager. “Her depth and breadth of experience will be of great value to both the RQA and regulatory bodies as she will be called upon to provide feedback on proposed changes to regulatory requirements.”